Cover Image

Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation

Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common neurodegenerative diseases with age as the greatest risk factor. As the general population experiences extended life span, preparation for the prevention and treatment of these and other age-associated neurological d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Amy H. Moore (Author), Matthew J. Bigbee (Author), Grace E. Boynton (Author), Colin M. Wakeham (Author), Hilary M. Rosenheim (Author), Christopher J. Staral (Author), James L. Morrissey (Author), Amanda K. Hund (Author)
Format:	Book
Published:	MDPI AG, 2010-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Targeting neuroinflammation in Alzheimer’s disease
by: Bronzuoli MR, et al.
Published: (2016)

Neuroinflammation in Alzheimer's disease: microglial signature and their relevance to disease
by: Akira Sobue, et al.
Published: (2023)

Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson's Disease
by: Sandeep Vasant More, et al.
Published: (2013)

Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer's Disease, Parkinson's Disease, and Autism Spectrum Disorder
by: Shilu Deepa Thomas, et al.
Published: (2024)

Non-Coding RNA in Microglia Activation and Neuroinflammation in Alzheimer’s Disease
by: He C, et al.
Published: (2023)

Neuroinflammation and Mitochondrial Dysfunction in Parkinson's Disease: Connecting Neuroimaging with Pathophysiology
by: Benjamin Matís Pizarro-Galleguillos, et al.
Published: (2023)

Behold the Eye in Parkinson's Disease & Alzheimer's Disease
Published: (2020)

Doxycycline for Alzheimer's Disease: Fighting β-Amyloid Oligomers and Neuroinflammation
by: Claudia Balducci, et al.
Published: (2019)

Role of Neuroinflammation in Adult Neurogenesis and Alzheimer Disease: Therapeutic Approaches
by: Almudena Fuster-Matanzo, et al.
Published: (2013)

Alzheimer's and Parkinson's disease therapies in the clinic
by: Puja Chopade, et al.
Published: (2023)

Oxidative Stress and Neuroinflammation in Parkinson's Disease: The Role of Dopamine Oxidation Products
by: Sasanka Chakrabarti, et al.
Published: (2023)

A Computational Exploration of the Molecular Network Associated to Neuroinflammation in Alzheimer's Disease
by: Fatima El Idrissi, et al.
Published: (2021)

Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer’s disease
by: Fiona E McAlpine, et al.
Published: (2008)

Parkinson's disease and Alzheimer's disease: a Mendelian randomization study
by: Zhifa Han, et al.
Published: (2018)

Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer's disease
by: Elham Nasiri, et al.
Published: (2020)

Revisiting the neuroinflammation hypothesis in Alzheimer's disease: a focus on the druggability of current targets
by: Maylin Wong-Guerra, et al.
Published: (2023)

An Exosome-Based Therapeutic Strategy Targeting Neuroinflammation in Alzheimer’s Disease with Berberine and Palmatine
by: Zhao X, et al.
Published: (2023)

AVE 0991 Suppresses Astrocyte-Mediated Neuroinflammation of Alzheimer’s Disease by Enhancing Autophagy
by: Deng Y, et al.
Published: (2023)

Prevention and Treatment Strategies for Alzheimer’s Disease: Focusing on Microglia and Astrocytes in Neuroinflammation
by: Zhang S, et al.
Published: (2024)

Icaritin Provides Neuroprotection in Parkinson's Disease by Attenuating Neuroinflammation, Oxidative Stress, and Energy Deficiency
by: Hao Wu, et al.
Published: (2021)

GSDMD in peripheral myeloid cells regulates microglial immune training and neuroinflammation in Parkinson's disease
by: Bingwei Wang, et al.
Published: (2023)

Dual task and postural control in Alzheimer's and Parkinson's disease
by: Larissa Pires de Andrade, et al.
Published: (2014)

Analyses of hospitalization in Alzheimer's disease and Parkinson's disease in a tertiary hospital
by: Sihui Chen, et al.
Published: (2023)

Alzheimer's Disease Blood Biomarkers Associated With Neuroinflammation as Therapeutic Targets for Early Personalized Intervention
by: Sher Li Oh, et al.
Published: (2022)

Dipeptide of ψ-GSH Inhibits Oxidative Stress and Neuroinflammation in an Alzheimer's Disease Mouse Model
by: Abbas Raza, et al.
Published: (2022)

Chuanxiong Renshen Decoction Inhibits Alzheimer’s Disease Neuroinflammation by Regulating PPARγ/NF-κB Pathway
by: Hou J, et al.
Published: (2024)

Dysregulation of Iron Metabolism in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis
by: Satoru Oshiro, et al.
Published: (2011)

Fetal programming of Parkinson's and Alzheimer's diseases: the role of epigenetic factors
by: Monica Piras, et al.
Published: (2014)

Dendrobium nobile alkaloids modulate calcium dysregulation and neuroinflammation in Alzheimer's disease: A bioinformatic analysis
by: Iman Touati, et al.
Published: (2024)

Memantine and its role in parkinsonism, seizure, depression, migraine headache, and Alzheimer's disease
by: Hany Akeel Al_hussaniy, et al.
Published: (2023)

CD44 deficiency represses neuroinflammation and rescues dopaminergic neurons in a mouse model of Parkinson's disease
by: Yuejun Wang, et al.
Published: (2022)

Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson's Disease Models
by: Matthew L. Neal, et al.
Published: (2023)

Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease
by: Ganguly G, et al.
Published: (2017)

Meridianins Rescue Cognitive Deficits, Spine Density and Neuroinflammation in the 5xFAD Model of Alzheimer's Disease
by: Ened Rodríguez-Urgellés, et al.
Published: (2022)

Comprehensive spectroscopic and computational insight into the binding of vanillin with human transferrin: targeting neuroinflammation in Alzheimer's disease therapeutics
by: Mohammed Alrouji, et al.
Published: (2024)

Alzheimer's disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?
by: Daniela Melchiorri, et al.
Published: (2023)

Impeding the combination of astrocytic ASCT2 and NLRP3 by talniflumate alleviates neuroinflammation in experimental models of Parkinson's disease
by: Yang Liu, et al.
Published: (2023)

Neutral Sphingomyelinase Behaviour in Hippocampus Neuroinflammation of MPTP-Induced Mouse Model of Parkinson's Disease and in Embryonic Hippocampal Cells
by: Samuela Cataldi, et al.
Published: (2017)

Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: A new perspective
by: Mohammed Alrouji, et al.
Published: (2024)

The VEGFs/VEGFRs system in Alzheimer's and Parkinson's diseases: Pathophysiological roles and therapeutic implications
by: Claudia Ceci, et al.
Published: (2024)